Erosion Of Congressional Support For Supercollider Frustrates, Angers Nation's High-Energy Physicists

Many of them argue that, without the SSC, the field of particle physics may lose its vitality--maybe even its future The struggle in Congress over funding for the superconducting supercollider (SSC)--now something of an annual event--is disrupting work at the laboratory and raising frustrations throughout the high-energy physics community, say physicists. Many of them also worry not only about the future of the multibillion-dollar Waxahachie, Texas, project, but also about that of part

Written byFranklin Hoke
| 6 min read

Register for free to listen to this article
Listen with Speechify
0:00
6:00
Share

Many of them argue that, without the SSC, the field of particle physics may lose its vitality--maybe even its future

The struggle in Congress over funding for the superconducting supercollider (SSC)--now something of an annual event--is disrupting work at the laboratory and raising frustrations throughout the high-energy physics community, say physicists. Many of them also worry not only about the future of the multibillion-dollar Waxahachie, Texas, project, but also about that of particle physics in the United States.

Already, failing support for the SSC in Washington, D.C., threatens recruitment to the project, they say, from student through professional levels. Some top particle physicists in the early to middle stages of their careers, disturbed by the prospect of waiting until the next century to begin experiments, are considering moves to accelerator laboratories outside the U.S., such as CERN in Geneva.

"What may be the most disturbing thing of all," says Steven ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies